
| OPPONENT | AB | R | H | 1B | 2B | 3B | HR | BB | RBI | SO | SAC | SB | AVG | SLG | OB | OPS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mondelez | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | .000 | .000 | .000 | .000 | |
| ASCO | 2 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | .500 | .500 | .667 | 1.167 | |
| Novartis #2 | 2 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | .500 | 1.500 | .500 | 2.000 | |
| Evonik | 2 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | .500 | .500 | .667 | 1.167 | |
| Pinnacle | 3 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | .333 | .333 | .400 | .733 | |
| TOTAL | 12 | 0 | 4 | 3 | 0 | 1 | 0 | 3 | 1 | 2 | 1 | 0 | .333 | .500 | .438 | .938 |